Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trial
scientific article
Author/s
author: David Dingli, Angela Dispenzieri, Martha Q Lacy, Stephen J. Russell, S. Vincent Rajkumar, Morie A Gertz, Suzanne R Hayman, Steven R Zeldenrust, John A. Lust, Francis K Buadi, Shaji K Kumar, P Leif Bergsagel, Craig B Reeder, Vivek Roy, Joseph Mikhael, Philip R. Greipp, Jacob B Allred, Kristina M Laumann, Rafael Fonseca
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.